| Business Name: |
Vim Drug CO |
| Contact Person: |
Rajan Pillay, Owner |
| Address: |
3835 Broadway, New York City, New York 10032 |
| Phone Number: |
(212) 927-0220 |
| Annual Revenue (USD): |
$1.000.000 to $2.499.999 |
| Founding Year: |
1991 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
|
| SIC Code: |
5912 |
| NAICS Code: |
4461100 |
| Share This Business: |
|
| Related Businesses: |
C & C Drug Inc - New York City, NY 10032
Columbia Pharmacy - New York City, NY 10032
Andy Pharmacy Inc - New York City, NY 10032
Vlvmed Pharmacy - New York City, NY 10032
3890 Broadway Pharmacy Iv Inc - New York City, NY 10032
Uptown Chemist - New York City, NY 10032
Citydrug & Surgical Inc - New York City, NY 10032
Rays Drug Store - New York City, NY 10032
Aggamin LLC - New York City, NY 10032
St Anthony Pharmacy Inc - New York City, NY 10032
Santa Barbara Drugs Inc - New York City, NY 10032
3817 Brdwy Pharmacy Inc - New York City, NY 10032
Citydrug & Surgical - New York City, NY 10032
158 Rx Corp - New York City, NY 10032
Babu Bhai Patel Physician Pc - New York City, NY 10032
Jmc Pharmacy Inc - New York City, NY 10032
Melbran Pharmacy Inc - New York City, NY 10032
J J Pharmacy CO Inc - New York City, NY 10032
Newman Lyman Drug CO - New York City, NY 10032
Doctor's Office - New York City, NY 10032
|
The company Vim Drug CO provides B2C services in the form of from its single location in New York.
1 to 4 employees work for Vim Drug CO, and the business now earns $1.000.000 to $2.499.999 per annum.
Vim Drug CO was launched in 1991 and is classified under SIC code and category 5912 , and NAICS number and grouping 4461100 .
To contact Vim Drug CO, please call Rajan Pillay, Owner with the phone number (212) 927-0220 or visit its single location at 3835 Broadway in New York City, New York 10032.
The location of the single location can also be found using the coordinates 40.83588,-73.94373.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.